David Altshuler
Vertex Pharmaceuticals
EVP & Chief Scientific Officer
Overview
David Altshuler made an average of $7.6M in compensation at Vertex Pharmaceuticals from 2015 to 2017.
Annual data
2017
In 2017, David Altshuler earned a total compensation of $5.7M as EVP & Chief Scientific Officer at Vertex Pharmaceuticals.
| Ranking | 1,445 out of 13,202 |
|---|---|
| Percentile | 89.1% |
David Altshuler's 2017 compensation ranked 1,445th out of 13,202 executive pay records tracked by us this year.
Altshuler earned more than 89.1% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 83 out of 1,399 |
| Percentile | 94.1% |
In the industry group of Drugs, Altshuler's pay ranked 83rd out of 1,399 executive pay records tracked by us in 2017.
Altshuler earned more than 94.1% of executives in this group.
| Non-Equity Incentive Plan | $638,250 |
|---|---|
| Option Awards | $1,332,316 |
| Salary | $596,731 |
| Stock Awards | $3,150,020 |
| Other | $13,110 |
| Total | $5,730,427 |
Altshuler received $3.2M in stock awards, which accounts for 54.97% of total compensation.
Altshuler also received $638.3K in non-equity incentive plan, $1.3M in option awards, $596.7K in salary and $13.1K in other compensation.
2016
In 2016, David Altshuler earned a total compensation of $4.8M as EVP & Chief Scientific Officer at Vertex Pharmaceuticals.
| Ranking | 1,690 out of 13,871 |
|---|---|
| Percentile | 87.8% |
David Altshuler's 2016 compensation ranked 1,690th out of 13,871 executive pay records tracked by us this year.
Altshuler earned more than 87.8% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 105 out of 1,472 |
| Percentile | 92.9% |
In the industry group of Drugs, Altshuler's pay ranked 105th out of 1,472 executive pay records tracked by us in 2016.
Altshuler earned more than 92.9% of executives in this group.
| Non-Equity Incentive Plan | $500,250 |
|---|---|
| Option Awards | $1,087,620 |
| Salary | $561,442 |
| Stock Awards | $2,625,152 |
| Other | $12,885 |
| Total | $4,787,349 |
Altshuler received $2.6M in stock awards, which accounts for 54.84% of total compensation.
Altshuler also received $500.3K in non-equity incentive plan, $1.1M in option awards, $561.4K in salary and $12.9K in other compensation.
2015
In 2015, David Altshuler earned a total compensation of $12.4M as EVP & Chief Scientific Officer at Vertex Pharmaceuticals.
| Ranking | 338 out of 13,574 |
|---|---|
| Percentile | 97.5% |
David Altshuler's 2015 compensation ranked 338th out of 13,574 executive pay records tracked by us this year.
Altshuler earned more than 97.5% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 39 out of 1,484 |
| Percentile | 97.4% |
In the industry group of Drugs, Altshuler's pay ranked 39th out of 1,484 executive pay records tracked by us in 2015.
Altshuler earned more than 97.4% of executives in this group.
| Bonus | $250,000 |
|---|---|
| Non-Equity Incentive Plan | $552,628 |
| Option Awards | $1,964,534 |
| Salary | $528,846 |
| Stock Awards | $9,078,750 |
| Other | $13,110 |
| Total | $12,387,868 |
Altshuler received $9.1M in stock awards, which accounts for 73.29% of total compensation.
Altshuler also received $250K in bonus, $552.6K in non-equity incentive plan, $2M in option awards, $528.8K in salary and $13.1K in other compensation.